https://scholars.lib.ntu.edu.tw/handle/123456789/201440
標題: | Value of Whole Body 18f-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Evaluation of Recurrent Cervical Cancer | 作者: | YEN, RUOH-FANG | 關鍵字: | 18F-fluoro-2-deoxyglucose positron emission tomography;cervical cancer;ONCOLOGY;PET | 公開日期: | 2001 | 卷: | v.21 | 期: | n.4B | 起(迄)頁: | 2957-2961 | 來源出版物: | ANTICANCER RESEARCH | 摘要: | To evaluate the clinical value of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose ( FDG) in recurrent cervical cancer, the records of 20 patients who underwent FDG-PET scans were reviewed to detect local recurrence, pelvic/para-aortic lymph node metastases and distal metastases. The final diagnosis was based on operative, histopathological findings or clinical follow-up for longer than one year. FDG-PET accurately detected 18 patients with recurrent diseases (12 patients with local recurrences, 16 patients with pelvic lymph node metastases, 14 patients with para-aortic lymph node metastases and 4 patients with distal metastases Of other sites). However, 2 patients with local recurrences had false-negative FDG-PET results as well as I patient without local recurrence and I patient without pelvic lymph node metastases who had false- positive FDG-PET results. The overall sensitivity and specificity of FDG-PET for patients were 90% and 100%, for local recurrence were 86% and 92%, for pelvic lymph node metastases were 100% and 94%, for para-aortic lymph node metastases were 100% and 100% and for distal metastases were 100% and 100%, respectively. In conclusion, whole body FDG- PET is a useful diagnostic tool in the evaluation of recurrent cervical cancer. It appears to be promising for detecting recurrent cervical cancer, lymph node metastases and distal metastases. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/96950 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。